NOTCH shows both oncogenic and tumour suppressor roles in different tissues and in the hematopoietic system: NOTCH favours cancer growth in T acute lymphoblastic leukaemia through its MYC activation but is also found to augment the host immune response against cancer by activation of M1 macrophages47. This evidence concerns the gene MYC and acute lymphoblastic leukemia.